BIOMAT Database Logo BIOMAT Database Logo

Construction of MDR1 vectors for gene therapy. 1998

Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Tokyo, Japan.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D001854 Bone Marrow Cells Cells contained in the bone marrow including fat cells (see ADIPOCYTES); STROMAL CELLS; MEGAKARYOCYTES; and the immediate precursors of most blood cells. Bone Marrow Cell,Cell, Bone Marrow,Cells, Bone Marrow,Marrow Cell, Bone,Marrow Cells, Bone
D003001 Cloning, Molecular The insertion of recombinant DNA molecules from prokaryotic and/or eukaryotic sources into a replicating vehicle, such as a plasmid or virus vector, and the introduction of the resultant hybrid molecules into recipient cells without altering the viability of those cells. Molecular Cloning
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D005822 Genetic Vectors DNA molecules capable of autonomous replication within a host cell and into which other DNA sequences can be inserted and thus amplified. Many are derived from PLASMIDS; BACTERIOPHAGES; or VIRUSES. They are used for transporting foreign genes into recipient cells. Genetic vectors possess a functional replicator site and contain GENETIC MARKERS to facilitate their selective recognition. Cloning Vectors,Shuttle Vectors,Vectors, Genetic,Cloning Vector,Genetic Vector,Shuttle Vector,Vector, Cloning,Vector, Genetic,Vector, Shuttle,Vectors, Cloning,Vectors, Shuttle
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000519 alpha-Galactosidase An enzyme that catalyzes the hydrolysis of terminal, non-reducing alpha-D-galactose residues in alpha-galactosides including galactose oligosaccharides, galactomannans, and galactolipids. Beano,Melibiase,alpha-D-Galactopyranosidase,alpha-D-Galactosidase,alpha-Galactisidase,alpha-Galactosidase A,alpha-Galactosidases,alpha D Galactopyranosidase,alpha D Galactosidase,alpha Galactisidase,alpha Galactosidase,alpha Galactosidase A,alpha Galactosidases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Construction of MDR1 adeno-associated virus vectors for gene therapy.
January 1998, Methods in enzymology,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Construction and characterization of retroviral vectors for interleukin-2 gene therapy.
November 1997, Journal of immunotherapy (Hagerstown, Md. : 1997),
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
An episomally maintained MDR1 gene for gene therapy.
May 2001, Human gene therapy,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
[Vectors for gene therapy].
April 1997, Medizinische Monatsschrift fur Pharmazeuten,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Construction and characterization of helper-dependent adenoviral vectors for sustained in vivo gene therapy.
January 2005, Methods in molecular medicine,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Anti-MDR1 Ribozyme Gene Therapy.
January 2000, Methods in molecular medicine,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Vectors for pulmonary gene therapy.
May 2010, International journal of pharmaceutics,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Mineralized vectors for gene therapy.
July 2022, Acta biomaterialia,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
Baculovirus vectors for gene therapy.
January 2006, Advances in virus research,
Y Sugimoto, and M M Gottesman, and I Pastan, and T Tsuruo
[Adenovirus vectors for gene therapy].
December 2003, Uirusu,
Copied contents to your clipboard!